Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Brain Imaging

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Depressive Disorders: Etiology

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Molecular, Structural, and Functional Neuroimaging in Major Depression.

Advances in experimental medicine and biology·2026

Same author

The alterations of degree centrality in the frontal lobe of patients with panic disorder.

International journal of medical sciences·2022

Same author

Editorial: Neuroimaging Biomarkers in Mood and Anxiety Disorders.

Frontiers in psychiatry·2021

Same author

Task MRI-Based Functional Brain Network of Major Depression.

Advances in experimental medicine and biology·2021

Same author

Fronto-limbic neuroimaging biomarkers for diagnosis and prediction of treatment responses in major depressive disorder.

Progress in neuro-psychopharmacology & biological psychiatry·2020

Same author

Task MRI-Based Functional Brain Network of Anxiety.

Advances in experimental medicine and biology·2020

Search research articles

Related Experiment Video

Updated: Jan 19, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Promising Neuroimaging Biomarkers in Depression.

Chien-Han Lai^1,2,3

¹Institute of Biophotonics, National Yang-Ming University, Taipei, Taiwan.

Psychiatry Investigation

|September 26, 2019

Summary

This summary is machine-generated.

Neuroimaging techniques reveal promising biomarkers for major depressive disorder (MDD) in fronto-limbic brain regions. These findings may aid in predicting treatment response and understanding MDD pathophysiology.

Keywords:

Anterior cingulate cortex Dorsolateral prefrontal cortex Fronto-limbic Hippocampus Major depressive disorder Orbitofrontal cortex

More Related Videos

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity

Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity

Published on: July 1, 2014

Related Experiment Videos

Last Updated: Jan 19, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity

Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity

Published on: July 1, 2014

Area of Science:

Neuroscience
Psychiatry
Medical Imaging

Background:

Major depressive disorder (MDD) pathophysiology is increasingly studied using neuroimaging.
Identifying reliable biomarkers is crucial for diagnosis and treatment prediction.

Purpose of the Study:

To review various neuroimaging methodologies for identifying biomarkers in MDD.
To summarize promising fronto-limbic regions as potential biomarkers for MDD.

Main Methods:

Literature review of neuroimaging studies including MRI, magnetoencephalography, near-infrared spectroscopy, electroencephalography, PET, and SPECT.
Analysis of findings related to specific brain regions like the frontal lobes and limbic system.

Main Results:

Magnetic resonance imaging and magnetoencephalography suggest the anterior cingulate cortex, dorsolateral prefrontal cortex, and orbitofrontal cortex as potential biomarkers.
Limbic regions including the hippocampus and amygdala are also identified as promising biomarkers.
Near-infrared spectroscopy, electroencephalography, PET, and SPECT studies corroborate the role of frontal and limbic regions, with PET/SPECT also highlighting brainstem and midbrain involvement.

Conclusions:

Frontal and limbic regions show significant promise as neuroimaging biomarkers for MDD.
These biomarkers may be valuable for predicting antidepressant treatment response and understanding MDD's underlying pathophysiology.
Cognitive control and emotion regulation functions within these regions are key to biomarker development.